Loading...

Toby Maher

Title(s)Professor of Clinical Medicine
AddressIRD 720 2020 Zonal Avenue
Health Sciences Campus
los angeles CA 90033
ORCID ORCID Icon0000-0001-7192-9149 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Southampton Medical School, UKBM1998Medicine
    Royal College of Physicians, London, UKFRCP2002Internal Medicine
    Imperial College London, LondonMSc2004Respiratory Medicine
    University College London, LondonPhD2009Medicine

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse In The News
    Collapse Twitter
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Can biomarkers of extracellular matrix remodelling and wound healing be used to identify high risk patients infected with SARS-CoV-2?: lessons learned from pulmonary fibrosis. Respir Res. 2021 Feb 05; 22(1):38. Leeming DJ, Genovese F, Sand JMB, Rasmussen DGK, Christiansen C, Jenkins G, Maher TM, Vestbo J, Karsdal MA. PMID: 33546680.
      View in: PubMed   Mentions:    Fields:    
    2. The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2021 Feb 01; 203(3):339-347. Invernizzi R, Wu BG, Barnett J, Ghai P, Kingston S, Hewitt RJ, Feary J, Li Y, Chua F, Wu Z, Wells AU, George PM, Renzoni EA, Nicholson AG, Rice A, Devaraj A, Segal LN, Byrne AJ, Maher TM, Lloyd CM, Molyneaux PL. PMID: 32692582.
      View in: PubMed   Mentions: 1     Fields:    
    3. Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2021 Jan 12. Kreuter M, Lee JS, Tzouvelekis A, Oldham JM, Molyneaux PL, Weycker D, Atwood M, Kirchgaessler KU, Maher TM. PMID: 33434107.
      View in: PubMed   Mentions:    Fields:    
    4. Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial. Eur Respir J. 2021 Jan 08. Noth I, Cottin V, Chaudhuri N, Corte TJ, Johannson KA, Wijsenbeek M, Jouneau S, Michael A, Quaresma M, Rohr KB, Russell AM, Stowasser S, Maher TM. PMID: 33419890.
      View in: PubMed   Mentions:    Fields:    
    5. Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial. Lancet Respir Med. 2021 01; 9(1):96-106. Highland KB, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, Denton CP, Distler JHW, Hoffmann-Vold AM, Khanna D, Mayes MD, Raghu G, Vonk MC, Gahlemann M, Clerisme-Beaty E, Girard M, Stowasser S, Zoz D, Maher TM. PMID: 33412120.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. BAL Is Safe and Well Tolerated in Individuals with Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Study. Am J Respir Crit Care Med. 2021 01 01; 203(1):136-139. Molyneaux PL, Smith JJ, Saunders P, Chua F, Wells AU, Renzoni EA, Nicholson AG, Fahy WA, Jenkins RG, Maher TM. PMID: 32857629.
      View in: PubMed   Mentions:    Fields:    
    7. Idiopathic pulmonary fibrosis: Disease mechanisms and drug development. Pharmacol Ther. 2020 Dec 24; 222:107798. Spagnolo P, Kropski JA, Jones MG, Lee JS, Rossi G, Karampitsakos T, Maher TM, Tzouvelekis A, Ryerson CJ. PMID: 33359599.
      View in: PubMed   Mentions:    Fields:    
    8. Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression. Respirology. 2020 Dec 17. Stock CJW, Hoyles RK, Daccord C, Kokosi M, Visca D, De Lauretis A, Alfieri V, Kouranos V, Margaritopoulos G, George PM, Molyneaux PL, Chua F, Maher TM, Abraham DJ, Ong V, Donovan J, Sestini P, Denton CP, Wells AU, Renzoni EA. PMID: 33336433.
      View in: PubMed   Mentions:    Fields:    
    9. Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial. JAMA. 2020 Dec 08; 324(22):2282-2291. Wilson AM, Clark AB, Cahn T, Chilvers ER, Fraser W, Hammond M, Livermore DM, Maher TM, Parfrey H, Swart AM, Stirling S, Thickett DR, Whyte M. PMID: 33289822.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    10. Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European Populations. Am J Respir Crit Care Med. 2020 Nov 23. Leavy OC, Ma SF, Molyneaux PL, Maher TM, Oldham JM, Flores C, Noth I, Jenkins RG, Dudbridge F, Wain LV, Allen RJ. PMID: 33226834.
      View in: PubMed   Mentions:    Fields:    
    11. Target-inhibition of Galectin-3 by Inhaled TD139 in Patients with Idiopathic Pulmonary Fibrosis. Eur Respir J. 2020 Nov 19. Hirani N, MacKinnon AC, Nicol L, Ford P, Schambye H, Pedersen A, Nilsson UJ, Leffler H, Sethi T, Tantawi S, Gavelle L, Slack RJ, Mills R, Karmakar U, Humphries D, Zetterberg F, Keeling L, Paul L, Molyneaux PL, Li F, Funston W, Forrest IA, Simpson AJ, Gibbons MA, Maher TM. PMID: 33214209.
      View in: PubMed   Mentions:    Fields:    
    12. Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesis. Thorax. 2021 Jan; 76(1):73-82. PMID: 33214245.
      View in: PubMed   Mentions:    Fields:    
    13. Effect of nintedanib on lung function in patients with systemic sclerosis-associated interstitial lung disease: further analyses of the SENSCIS trial. Arthritis Rheumatol. 2020 Nov 03. Maher TM, Mayes MD, Kreuter M, Volkmann ER, Aringer M, Castellvi I, Cutolo M, Stock C, Schoof N, Alves M, Raghu G. PMID: 33142016.
      View in: PubMed   Mentions:    Fields:    
    14. Itaconate controls the severity of pulmonary fibrosis. Sci Immunol. 2020 Oct 23; 5(52). Ogger PP, Albers GJ, Hewitt RJ, O'Sullivan BJ, Powell JE, Calamita E, Ghai P, Walker SA, McErlean P, Saunders P, Kingston S, Molyneaux PL, Halket JM, Gray R, Chambers DC, Maher TM, Lloyd CM, Byrne AJ. PMID: 33097591.
      View in: PubMed   Mentions: 1     Fields:    
    15. Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2020 Oct 02. Maher TM, Costabel U, Glassberg MK, Kondoh Y, Ogura T, Scholand MB, Kardatzke D, Howard M, Olsson J, Neighbors M, Belloni P, Swigris JJ. PMID: 33008934.
      View in: PubMed   Mentions:    Fields:    
    16. Translational pharmacology of an inhaled small molecule avß6 integrin inhibitor for idiopathic pulmonary fibrosis. Nat Commun. 2020 09 16; 11(1):4659. John AE, Graves RH, Pun KT, Vitulli G, Forty EJ, Mercer PF, Morrell JL, Barrett JW, Rogers RF, Hafeji M, Bibby LI, Gower E, Morrison VS, Man Y, Roper JA, Luckett JC, Borthwick LA, Barksby BS, Burgoyne RA, Barnes R, Le J, Flint DJ, Pyne S, Habgood A, Organ LA, Joseph C, Edwards-Pritchard RC, Maher TM, Fisher AJ, Gudmann NS, Leeming DJ, Chambers RC, Lukey PT, Marshall RP, Macdonald SJF, Jenkins RG, Slack RJ. PMID: 32938936.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    17. Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis. Nat Commun. 2020 Sep 11; 11(1):4680. Woodcock HV, Eley JD, Guillotin D, Platé M, Nanthakumar CB, Martufi M, Peace S, Joberty G, Poeckel D, Good RB, Taylor AR, Zinn N, Redding M, Forty EJ, Hynds RE, Swanton C, Karsdal M, Maher TM, Fisher A, Bergamini G, Marshall RP, Blanchard AD, Mercer PF, Chambers RC. PMID: 32917879.
      View in: PubMed   Mentions:    Fields:    
    18. Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial. Ann Rheum Dis. 2020 11; 79(11):1478-1484. PMID: 32759258.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease. Respir Res. 2020 Jul 23; 21(1):197. Hoffmann-Vold AM, Allanore Y, Bendstrup E, Bruni C, Distler O, Maher TM, Wijsenbeek M, Kreuter M. PMID: 32703199.
      View in: PubMed   Mentions:    Fields:    
    20. Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact. Eur Respir J. 2020 07; 56(1). Bonifazi M, Sverzellati N, Negri E, Jacob J, Egashira R, Moser J, Piciucchi S, Mei F, De Lauretis A, Visca D, Goh N, Bonini M, Cirilli L, La Vecchia C, Chua F, Kouranos V, Margaritopoulos G, Kokosi M, Maher TM, Gasparini S, Gabrielli A, Wells AU, Renzoni EA. PMID: 32299855.
      View in: PubMed   Mentions:    Fields:    
    21. Chronic hypersensitivity pneumonitis; an enigmatic and frequently fatal disease. Eur Respir Rev. 2020 Jun 30; 29(156). Maher TM. PMID: 32641390.
      View in: PubMed   Mentions:    Fields:    
    22. Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype? Thorax. 2020 10; 75(10):901-903. Stock CJ, Conti C, Montero-Fernandez Á, Caramori G, Molyneaux PL, George PM, Kokosi M, Kouranos V, Maher TM, Chua F, Rice A, Denton CP, Nicholson AG, Wells A, Sestini P, Renzoni EA. PMID: 32580994.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    23. Shedding light on developmental drugs for idiopathic pulmonary fibrosis. Expert Opin Investig Drugs. 2020 Aug; 29(8):797-808. Spagnolo P, Bonella F, Ryerson CJ, Tzouvelekis A, Maher TM. PMID: 32538186.
      View in: PubMed   Mentions:    Fields:    
    24. Mixed Ventilatory Defects in Pulmonary Sarcoidosis: Prevalence and Clinical Features. Chest. 2020 Nov; 158(5):2007-2014. Kouranos V, Ward S, Kokosi MA, Castillo D, Chua F, Judge EP, Thomas S, Van Tonder F, Devaraj A, Nicholson AG, Maher TM, Renzoni EA, Wells AU. PMID: 32534908.
      View in: PubMed   Mentions:    Fields:    
    25. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA. Adv Ther. 2020 07; 37(7):3292-3298. Olson AL, Maher TM, Acciai V, Mounir B, Quaresma M, Zouad-Lejour L, Wells CD, De Loureiro L. PMID: 32451950.
      View in: PubMed   Mentions:    Fields:    
    26. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med. 2020 08; 8(8):750-752. Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Casa GD, Sverzellati N, Maher TM. PMID: 32422177.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCellsPHPublic Health
    27. Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur Respir J. 2020 05; 55(5). Distler O, Assassi S, Cottin V, Cutolo M, Danoff SK, Denton CP, Distler JHW, Hoffmann-Vold AM, Johnson SR, Müller Ladner U, Smith V, Volkmann ER, Maher TM. PMID: 32079645.
      View in: PubMed   Mentions: 3     Fields:    
    28. Opportunities to diagnose fibrotic lung diseases in routine care: A primary care cohort study. Respirology. 2020 Dec; 25(12):1274-1282. Jones MG, Hillyar CRT, Nibber A, Chisholm A, Wilson A, Maher TM, Kaplan A, Price D, Walsh S, Richeldi L. PMID: 32390252.
      View in: PubMed   Mentions:    Fields:    
    29. Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Call to Arms. Am J Respir Crit Care Med. 2020 05 01; 201(9):1030-1032. Kreuter M, Maher TM. PMID: 31978310.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Healthcare Resource Utilization Among Patients in England with Systemic Sclerosis-Associated Interstitial Lung Disease: A Retrospective Database Analysis. Adv Ther. 2020 05; 37(5):2460-2476. Gayle A, Schoof N, Alves M, Clarke D, Raabe C, Das P, Del Galdo F, Maher TM. PMID: 32319038.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype. Chest. 2020 Aug; 158(2):646-659. Inoue Y, Kaner RJ, Guiot J, Maher TM, Tomassetti S, Moiseev S, Kuwana M, Brown KK. PMID: 32268131.
      View in: PubMed   Mentions: 2     Fields:    
    32. Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent. Eur Respir J. 2020 04; 55(4). Invernizzi R, Barnett J, Rawal B, Nair A, Ghai P, Kingston S, Chua F, Wu Z, Wells AU, Renzoni ER, Nicholson AG, Rice A, Lloyd CM, Byrne AJ, Maher TM, Devaraj A, Molyneaux PL. PMID: 31980496.
      View in: PubMed   Mentions: 7     Fields:    
    33. Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation. Eur Respir J. 2020 04; 55(4). Kreuter M, Polke M, Walsh SLF, Krisam J, Collard HR, Chaudhuri N, Avdeev S, Behr J, Calligaro G, Corte T, Flaherty K, Funke-Chambour M, Kolb M, Kondoh Y, Maher TM, Molina Molina M, Morais A, Moor CC, Morisset J, Pereira C, Quadrelli S, Selman M, Tzouvelekis A, Valenzuela C, Vancheri C, Vicens-Zygmunt V, Wälscher J, Wuyts W, Wijsenbeek M, Cottin V, Bendstrup E. PMID: 32060068.
      View in: PubMed   Mentions: 3     Fields:    
    34. A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled avß6 integrin inhibitor. Respir Res. 2020 Mar 26; 21(1):75. Maher TM, Simpson JK, Porter JC, Wilson FJ, Chan R, Eames R, Cui Y, Siederer S, Parry S, Kenny J, Slack RJ, Sahota J, Paul L, Saunders P, Molyneaux PL, Lukey PT, Rizzo G, Searle GE, Marshall RP, Saleem A, Kang'ombe AR, Fairman D, Fahy WA, Vahdati-Bolouri M. PMID: 32216814.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    35. Dynamics of human monocytes and airway macrophages during healthy aging and after transplant. J Exp Med. 2020 03 02; 217(3). Byrne AJ, Powell JE, O'Sullivan BJ, Ogger PP, Hoffland A, Cook J, Bonner KL, Hewitt RJ, Wolf S, Ghai P, Walker SA, Lukowski SW, Molyneaux PL, Saglani S, Chambers DC, Maher TM, Lloyd CM. PMID: 31917836.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    36. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2020 03 01; 201(5):564-574. Allen RJ, Guillen-Guio B, Oldham JM, Ma SF, Dressen A, Paynton ML, Kraven LM, Obeidat M, Li X, Ng M, Braybrooke R, Molina-Molina M, Hobbs BD, Putman RK, Sakornsakolpat P, Booth HL, Fahy WA, Hart SP, Hill MR, Hirani N, Hubbard RB, McAnulty RJ, Millar AB, Navaratnam V, Oballa E, Parfrey H, Saini G, Whyte MKB, Zhang Y, Kaminski N, Adegunsoye A, Strek ME, Neighbors M, Sheng XR, Gudmundsson G, Gudnason V, Hatabu H, Lederer DJ, Manichaikul A, Newell JD, O'Connor GT, Ortega VE, Xu H, Fingerlin TE, Bossé Y, Hao K, Joubert P, Nickle DC, Sin DD, Timens W, Furniss D, Morris AP, Zondervan KT, Hall IP, Sayers I, Tobin MD, Maher TM, Cho MH, Hunninghake GM, Schwartz DA, Yaspan BL, Molyneaux PL, Flores C, Noth I, Jenkins RG, Wain LV. PMID: 31710517.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    37. Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease. Eur Respir J. 2020 02; 55(2). Alfieri V, Crisafulli E, Visca D, Chong WH, Stock C, Mori L, de Lauretis A, Tsipouri V, Chua F, Kouranos V, Kokosi M, Hogben C, Molyneaux PL, George PM, Maher TM, Chetta AA, Sestini P, Wells AU, Renzoni EA. PMID: 31699833.
      View in: PubMed   Mentions:    Fields:    
    38. Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: preliminary evidence from the AmbOx Trial. Eur Respir J. 2020 02; 55(2). Whitty JA, Rankin J, Visca D, Tsipouri V, Mori L, Spencer L, Adamali H, Maher TM, Hopkinson NS, Birring SS, Farquhar M, Wells AU, Sestini P, Renzoni EA. PMID: 31699838.
      View in: PubMed   Mentions:    Fields:    
    39. Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials. Respir Res. 2020 Jan 30; 21(1):36. Kreuter M, Wuyts WA, Wijsenbeek M, Bajwah S, Maher TM, Stowasser S, Male N, Stansen W, Schoof N, Orsatti L, Swigris J. PMID: 32000772.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    40. Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease. Clin Rheumatol. 2020 Apr; 39(4):1173-1179. Stock CJW, De Lauretis A, Visca D, Daccord C, Kokosi M, Kouranos V, Margaritopoulos G, George PM, Molyneaux PL, Nihtyanova S, Chua F, Maher TM, Ong V, Abraham DJ, Denton CP, Wells AU, Wain LV, Renzoni EA. PMID: 31916109.
      View in: PubMed   Mentions: 2     Fields:    
    41. Clinical quantification of the integrin avß6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study). Eur J Nucl Med Mol Imaging. 2020 04; 47(4):967-979. Lukey PT, Coello C, Gunn R, Parker C, Wilson FJ, Saleem A, Garman N, Costa M, Kendrick S, Onega M, Kang'ombe AR, Listanco A, Davies J, Ramada-Magalhaes J, Moz S, Fahy WA, Maher TM, Jenkins G, Passchier J, Marshall RP. PMID: 31814068.
      View in: PubMed   Mentions: 2     Fields:    
    42. Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 12 01; 200(11):1402-1413. Hobbs BD, Putman RK, Araki T, Nishino M, Gudmundsson G, Gudnason V, Eiriksdottir G, Zilhao Nogueira NR, Dupuis J, Xu H, O'Connor GT, Manichaikul A, Nguyen J, Podolanczuk AJ, Madahar P, Rotter JI, Lederer DJ, Barr RG, Rich SS, Ampleford EJ, Ortega VE, Peters SP, O'Neal WK, Newell JD, Bleecker ER, Meyers DA, Allen RJ, Oldham JM, Ma SF, Noth I, Jenkins RG, Maher TM, Hubbard RB, Wain LV, Fingerlin TE, Schwartz DA, Washko GR, Rosas IO, Silverman EK, Hatabu H, Cho MH, Hunninghake GM. PMID: 31339356.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    43. The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis. Int J Mol Sci. 2019 Nov 10; 20(22). Spagnolo P, Molyneaux PL, Bernardinello N, Cocconcelli E, Biondini D, Fracasso F, Tiné M, Saetta M, Maher TM, Balestro E. PMID: 31717661.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    44. Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 11 01; 200(9):1146-1153. Walsh SLF, Lederer DJ, Ryerson CJ, Kolb M, Maher TM, Nusser R, Poletti V, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown KK, Corte TJ, Cottin V, Crestani B, Flaherty KR, Glaspole IN, Grutters J, Inoue Y, Kondoh Y, Kreuter M, Johannson KA, Ley B, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts WA, Wells AU. PMID: 31241357.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    45. Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. Reply. N Engl J Med. 2019 10 17; 381(16):1596-1597. Distler O, Gahlemann M, Maher TM. PMID: 31618556.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    46. Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease. Expert Rev Clin Immunol. 2019 10; 15(10):1009-1017. Distler O, Volkmann ER, Hoffmann-Vold AM, Maher TM. PMID: 31566449.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    47. Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis. Eur Respir J. 2019 09; 54(3). Jacob J, Bartholmai BJ, van Moorsel CHM, Rajagopalan S, Devaraj A, van Es HW, Moua T, van Beek FT, Clay R, Veltkamp M, Kokosi M, de Lauretis A, Judge EP, Jacob TM, Peikert T, Karwoski R, Maldonado F, Renzoni E, Maher TM, Altmann A, Wells AU. PMID: 31196945.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    48. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir Med. 2020 02; 8(2):147-157. Maher TM, Corte TJ, Fischer A, Kreuter M, Lederer DJ, Molina-Molina M, Axmann J, Kirchgaessler KU, Samara K, Gilberg F, Cottin V. PMID: 31578169.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    49. Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design. Adv Ther. 2019 11; 36(11):3059-3070. Santermans E, Ford P, Kreuter M, Verbruggen N, Meyvisch P, Wuyts WA, Brown KK, Lederer DJ, Byrne AJ, Molyneaux PL, Sivananthan A, Moor CC, Maher TM, Wijsenbeek M. PMID: 31565781.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis. Sci Transl Med. 2019 09 25; 11(511). Ng B, Dong J, D'Agostino G, Viswanathan S, Widjaja AA, Lim WW, Ko NSJ, Tan J, Chothani SP, Huang B, Xie C, Pua CJ, Chacko AM, Guimarães-Camboa N, Evans SM, Byrne AJ, Maher TM, Liang J, Jiang D, Noble PW, Schafer S, Cook SA. PMID: 31554736.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    51. Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases. Eur Respir J. 2019 09; 54(3). Wollin L, Distler JHW, Redente EF, Riches DWH, Stowasser S, Schlenker-Herceg R, Maher TM, Kolb M. PMID: 31285305.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    52. Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat. Respir Res. 2019 Sep 06; 20(1):205. Maher TM, Strek ME. PMID: 31492155.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    53. King's Brief Interstitial Lung Disease questionnaire: responsiveness and minimum clinically important difference. Eur Respir J. 2019 09; 54(3). Nolan CM, Birring SS, Maddocks M, Maher TM, Patel S, Barker RE, Jones SE, Walsh JA, Wynne SC, George PM, Man WD. PMID: 31221807.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    54. Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis. Eur Respir J. 2019 07; 54(1). Barnett J, Molyneaux PL, Rawal B, Abdullah R, Hare SS, Vancheeswaran R, Desai SR, Maher TM, Wells AU, Devaraj A. PMID: 31164428.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    55. Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study. Lancet Respir Med. 2019 09; 7(9):771-779. Maher TM, Stowasser S, Nishioka Y, White ES, Cottin V, Noth I, Selman M, Rohr KB, Michael A, Ittrich C, Diefenbach C, Jenkins RG. PMID: 31326319.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    56. The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 07 15; 200(2):209-219. Allden SJ, Ogger PP, Ghai P, McErlean P, Hewitt R, Toshner R, Walker SA, Saunders P, Kingston S, Molyneaux PL, Maher TM, Lloyd CM, Byrne AJ. PMID: 31051082.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    57. Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 07 15; 200(2):199-208. Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, Bishop M, Russell P, Vestal B, Cardwell J, Markin CR, Mathai SK, Schwarz MI, Steele MP, Lee J, Brown KK, Loyd JE, Crapo JD, Silverman EK, Cho MH, James JA, Guthridge JM, Cogan JD, Kropski JA, Swigris JJ, Bair C, Kim DS, Ji W, Kim H, Song JW, Maier LA, Pacheco KA, Hirani N, Poon AS, Li F, Jenkins RG, Braybrooke R, Saini G, Maher TM, Molyneaux PL, Saunders P, Zhang Y, Gibson KF, Kass DJ, Rojas M, Sembrat J, Wolters PJ, Collard HR, Sundy JS, O'Riordan T, Strek ME, Noth I, Ma SF, Porteous MK, Kreider ME, Patel NB, Inoue Y, Hirose M, Arai T, Akagawa S, Eickelberg O, Fernandez IE, Behr J, Mogulkoc N, Corte TJ, Glaspole I, Tomassetti S, Ravaglia C, Poletti V, Crestani B, Borie R, Kannengiesser C, Parfrey H, Fiddler C, Rassl D, Molina-Molina M, Machahua C, Worboys AM, Gudmundsson G, Isaksson HJ, Lederer DJ, Podolanczuk AJ, Montesi SB, Bendstrup E, Danchel V, Selman M, Pardo A, Henry MT, Keane MP, Doran P, Vašáková M, Sterclova M, Ryerson CJ, Wilcox PG, Okamoto T, Furusawa H, Miyazaki Y, Laurent G, Baltic S, Prele C, Moodley Y, Shea BS, Ohta K, Suzukawa M, Narumoto O, Nathan SD, Venuto DC, Woldehanna ML, Kokturk N, de Andrade JA, Luckhardt T, Kulkarni T, Bonella F, Donnelly SC, McElroy A, Armstong ME, Aranda A, Carbone RG, Puppo F, Beckman KB, Nickerson DA, Fingerlin TE, Schwartz DA. PMID: 31034279.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    58. Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort. Respir Res. 2019 Jul 12; 20(1):148. Organ LA, Duggan AR, Oballa E, Taggart SC, Simpson JK, Kang'ombe AR, Braybrooke R, Molyneaux PL, North B, Karkera Y, Leeming DJ, Karsdal MA, Nanthakumar CB, Fahy WA, Marshall RP, Jenkins RG, Maher TM. PMID: 31299951.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    59. Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation. Ann Am Thorac Soc. 2019 07; 16(7):927-930. Maher TM, Lancaster LH, Jouneau S, Morrison L, Lederer DJ, Molina-Molina M, Bendstrup E, Kirchgaessler KU, Gilberg F, Axmann J, Petzinger U, Noble PW. PMID: 30950636.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    60. Idiopathic Pulmonary Fibrosis: New and Emerging Treatment Options. Drugs Aging. 2019 06; 36(6):485-492. Hewitt RJ, Maher TM. PMID: 30864023.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    61. In patients with idiopathic pulmonary fibrosis the presence of hiatus hernia is associated with disease progression and mortality. Eur Respir J. 2019 05; 53(5). Mackintosh JA, Desai SR, Adamali H, Patel K, Chua F, Devaraj A, Kouranos V, Kokosi M, Margaritopoulos G, Renzoni EA, Wells AU, Molyneaux PL, Kumar S, Maher TM, George PM. PMID: 30923184.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Management of Fibrosing Interstitial Lung Diseases. Adv Ther. 2019 07; 36(7):1518-1531. Maher TM, Wuyts W. PMID: 31119691.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    63. Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2). BMJ Open Respir Res. 2019; 6(1):e000422. Maher TM, Kreuter M, Lederer DJ, Brown KK, Wuyts W, Verbruggen N, Stutvoet S, Fieuw A, Ford P, Abi-Saab W, Wijsenbeek M. PMID: 31179008.
      View in: PubMed   Mentions:
    64. Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. N Engl J Med. 2019 06 27; 380(26):2518-2528. Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM. PMID: 31112379.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    65. Patient-reported distress can aid clinical decision-making in idiopathic pulmonary fibrosis: analysis of the PROFILE cohort. Eur Respir J. 2019 05; 53(5). Stewart I, McKeever T, Braybrooke R, Oballa E, Simpson JK, Maher TM, Marshall RP, Lukey PT, Fahy WA, Jenkins G, Saini G. PMID: 30846471.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    66. Can monocytes predict prognosis of idiopathic pulmonary fibrosis? Lancet Respir Med. 2019 06; 7(6):467-469. Kreuter M, Maher TM. PMID: 30935880.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    67. A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis. Eur Respir J. 2019 03; 53(3). Lukey PT, Harrison SA, Yang S, Man Y, Holman BF, Rashidnasab A, Azzopardi G, Grayer M, Simpson JK, Bareille P, Paul L, Woodcock HV, Toshner R, Saunders P, Molyneaux PL, Thielemans K, Wilson FJ, Mercer PF, Chambers RC, Groves AM, Fahy WA, Marshall RP, Maher TM. PMID: 30765508.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    68. Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use. Pharmacoecon Open. 2019 Mar; 3(1):81-91. Diamantopoulos A, Maher TM, Schoof N, Esser D, LeReun C. PMID: 29943133.
      View in: PubMed   Mentions:
    69. The King's Brief Interstitial Lung Disease (KBILD) questionnaire: an updated minimal clinically important difference. BMJ Open Respir Res. 2019; 6(1):e000363. Sinha A, Patel AS, Siegert RJ, Bajwah S, Maher TM, Renzoni EA, Wells AU, Higginson IJ, Birring SS. PMID: 30956799.
      View in: PubMed   Mentions:
    70. Sarcoidosis in the UK: insights from British Thoracic Society registry data. BMJ Open Respir Res. 2019; 6(1):e000357. Thillai M, Chang W, Chaudhuri N, Forrest I, Ho LP, Lines S, Maher TM, Spencer LG, Spiteri M, Coker R. PMID: 30956798.
      View in: PubMed   Mentions:
    71. The potential impact of azithromycin in idiopathic pulmonary fibrosis. Eur Respir J. 2019 02; 53(2). Macaluso C, Maritano Furcada J, Alzaher O, Chaube R, Chua F, Wells AU, Maher TM, George PM, Renzoni EA, Molyneaux PL. PMID: 30442715.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    72. Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study. Eur Respir J. 2019 02; 53(2). Nolan CM, Maddocks M, Maher TM, Banya W, Patel S, Barker RE, Jones SE, George PM, Cullinan P, Man WD. PMID: 30487200.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    73. Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. QJM. 2019 02 01; 112(2):81-93. Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SC. PMID: 30605544.
      View in: PubMed   Mentions: 1     Fields:    
    74. No relevant pharmacokinetic drug-drug interaction between nintedanib and pirfenidone. Eur Respir J. 2019 01; 53(1). Richeldi L, Fletcher S, Adamali H, Chaudhuri N, Wiebe S, Wind S, Hohl K, Baker A, Schlenker-Herceg R, Stowasser S, Maher TM. PMID: 30442716.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    75. Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. Arthritis Rheumatol. 2019 02; 71(2):182-195. Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SC. PMID: 30604506.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    76. Predicting outcomes in rheumatoid arthritis related interstitial lung disease. Eur Respir J. 2019 01; 53(1). Jacob J, Hirani N, van Moorsel CHM, Rajagopalan S, Murchison JT, van Es HW, Bartholmai BJ, van Beek FT, Struik MHL, Stewart GA, Kokosi M, Egashira R, Brun AL, Cross G, Barnett J, Devaraj A, Margaritopoulos G, Karwoski R, Renzoni E, Maher TM, Wells AU. PMID: 30487199.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    77. The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis. Nat Commun. 2019 01 02; 10(1):6. Woodcock HV, Eley JD, Guillotin D, Platé M, Nanthakumar CB, Martufi M, Peace S, Joberty G, Poeckel D, Good RB, Taylor AR, Zinn N, Redding M, Forty EJ, Hynds RE, Swanton C, Karsdal M, Maher TM, Fisher A, Bergamini G, Marshall RP, Blanchard AD, Mercer PF, Chambers RC. PMID: 30602778.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    78. Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis. Am J Respir Crit Care Med. 2019 01 01; 199(1):12-21. Wu X, Kim GH, Salisbury ML, Barber D, Bartholmai BJ, Brown KK, Conoscenti CS, De Backer J, Flaherty KR, Gruden JF, Hoffman EA, Humphries SM, Jacob J, Maher TM, Raghu G, Richeldi L, Ross BD, Schlenker-Herceg R, Sverzellati N, Wells AU, Martinez FJ, Lynch DA, Goldin J, Walsh SLF. PMID: 29986154.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    79. Regularized Latent Class Model for Joint Analysis of High-Dimensional Longitudinal Biomarkers and a Time-to-Event Outcome. Biometrics. 2019 03; 75(1):69-77. Sun J, Herazo-Maya JD, Molyneaux PL, Maher TM, Kaminski N, Zhao H. PMID: 30178494.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    80. Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis. Respir Med. 2019 01; 146:42-48. Brown KK, Flaherty KR, Cottin V, Raghu G, Inoue Y, Azuma A, Huggins JT, Richeldi L, Stowasser S, Stansen W, Schlenker-Herceg R, Maher TM, Wells AU. PMID: 30665517.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    81. Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice. ERJ Open Res. 2018 Oct; 4(4). Fletcher SV, Jones MG, Renzoni EA, Parfrey H, Hoyles RK, Spinks K, Kokosi M, Kwok A, Warburton C, Titmuss V, Thillai M, Simler N, Maher TM, Brereton CJ, Chua F, Wells AU, Richeldi L, Spencer LG. PMID: 30364342.
      View in: PubMed   Mentions:
    82. Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study. ERJ Open Res. 2018 Oct; 4(4). Cottin V, Koschel D, Günther A, Albera C, Azuma A, Sköld CM, Tomassetti S, Hormel P, Stauffer JL, Strombom I, Kirchgaessler KU, Maher TM. PMID: 30364407.
      View in: PubMed   Mentions:
    83. PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-ß1 production. Sci Transl Med. 2018 09 26; 10(460). Celada LJ, Kropski JA, Herazo-Maya JD, Luo W, Creecy A, Abad AT, Chioma OS, Lee G, Hassell NE, Shaginurova GI, Wang Y, Johnson JE, Kerrigan A, Mason WR, Baughman RP, Ayers GD, Bernard GR, Culver DA, Montgomery CG, Maher TM, Molyneaux PL, Noth I, Mutsaers SE, Prele CM, Peebles RS, Newcomb DC, Kaminski N, Blackwell TS, Van Kaer L, Drake WP. PMID: 30257954.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    84. Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis. Am J Respir Crit Care Med. 2018 09 15; 198(6):767-776. Jacob J, Bartholmai BJ, Rajagopalan S, van Moorsel CHM, van Es HW, van Beek FT, Struik MHL, Kokosi M, Egashira R, Brun AL, Nair A, Walsh SLF, Cross G, Barnett J, de Lauretis A, Judge EP, Desai S, Karwoski R, Ourselin S, Renzoni E, Maher TM, Altmann A, Wells AU. PMID: 29684284.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    85. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial. BMJ Open Respir Res. 2018; 5(1):e000289. Maher TM, Corte TJ, Fischer A, Kreuter M, Lederer DJ, Molina-Molina M, Axmann J, Kirchgaessler KU, Cottin V. PMID: 30233802.
      View in: PubMed   Mentions:
    86. Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial. Lancet Respir Med. 2018 10; 6(10):759-770. Visca D, Mori L, Tsipouri V, Fleming S, Firouzi A, Bonini M, Pavitt MJ, Alfieri V, Canu S, Bonifazi M, Boccabella C, De Lauretis A, Stock CJW, Saunders P, Montgomery A, Hogben C, Stockford A, Pittet M, Brown J, Chua F, George PM, Molyneaux PL, Margaritopoulos GA, Kokosi M, Kouranos V, Russell AM, Birring SS, Chetta A, Maher TM, Cullinan P, Hopkinson NS, Banya W, Whitty JA, Adamali H, Spencer LG, Farquhar M, Sestini P, Wells AU, Renzoni EA. PMID: 30170904.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    87. Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial. BMJ Open Respir Res. 2018; 5(1):e000325. Maher TM, Stowasser S, Nishioka Y, White ES, Cottin V, Noth I, Selman M, Blahova Z, Wachtlin D, Diefenbach C, Jenkins RG. PMID: 30167310.
      View in: PubMed   Mentions:
    88. Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views. Respiration. 2018; 96(6):514-524. Maher TM, Swigris JJ, Kreuter M, Wijsenbeek M, Cassidy N, Ireland L, Axmann J, Nathan SD. PMID: 30114692.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    89. Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary Fibrosis. Respiration. 2018; 96(4):314-322. Spagnolo P, Kreuter M, Maher TM, Wuyts W, Bonella F, Corte TJ, Kopf S, Weycker D, Kirchgaessler KU, Ryerson CJ. PMID: 30025392.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    90. Rapidly Progressive Cystic Lung Disease. Am J Respir Crit Care Med. 2018 07 15; 198(2):264. Rogers C, Kent-Bramer J, Devaraj A, Nicholson AG, Molyneaux PL, Wells AU, Saikia S, Maher TM, George PM. PMID: 29625015.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    91. The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review. Pharmacoeconomics. 2018 07; 36(7):779-807. Diamantopoulos A, Wright E, Vlahopoulou K, Cornic L, Schoof N, Maher TM. PMID: 29492843.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    92. Gazing into the crystal ball: can treatment response be predicted in IPF? Lancet Respir Med. 2018 08; 6(8):570-572. Kreuter M, Maher T. PMID: 30072104.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    93. Could quality be the key in connective tissue disease-associated interstitial lung disease? Respirology. 2018 Jun 13. Molyneaux PL, Maher TM. PMID: 29897157.
      View in: PubMed   Mentions:    Fields:    
    94. Improved quantitation and reproducibility in multi-PET/CT lung studies by combining CT information. EJNMMI Phys. 2018 Jun 05; 5(1):14. Holman BF, Cuplov V, Millner L, Endozo R, Maher TM, Groves AM, Hutton BF, Thielemans K. PMID: 29869186.
      View in: PubMed   Mentions:
    95. Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial. Lancet Respir Med. 2018 08; 6(8):627-635. Maher TM, van der Aar EM, Van de Steen O, Allamassey L, Desrivot J, Dupont S, Fagard L, Ford P, Fieuw A, Wuyts W. PMID: 29792287.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    96. Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK. Adv Ther. 2018 May; 35(5):724-736. Strongman H, Kausar I, Maher TM. PMID: 29644539.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    97. Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis. Respiration. 2018; 95(5):317-326. Kreuter M, Costabel U, Richeldi L, Cottin V, Wijsenbeek M, Bonella F, Bendstrup E, Maher TM, Wachtlin D, Stowasser S, Kolb M. PMID: 29414827.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    98. The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis. Respir Res. 2018 02 06; 19(1):25. Usmani OS, Biddiscombe MF, Yang S, Meah S, Oballa E, Simpson JK, Fahy WA, Marshall RP, Lukey PT, Maher TM. PMID: 29409488.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    99. The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial. Trials. 2018 Feb 05; 19(1):89. Hammond M, Clark AB, Cahn AP, Chilvers ER, Fraser WD, Livermore DM, Maher TM, Parfrey H, Swart AM, Stirling S, Thickett D, Whyte M, Wilson A. PMID: 29402332.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    100. Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? Lancet Respir Med. 2018 02; 6(2):154-160. Wolters PJ, Blackwell TS, Eickelberg O, Loyd JE, Kaminski N, Jenkins G, Maher TM, Molina-Molina M, Noble PW, Raghu G, Richeldi L, Schwarz MI, Selman M, Wuyts WA, Schwartz DA. PMID: 29413083.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    101. Combination Therapy and the Start of a New Epoch for Idiopathic Pulmonary Fibrosis? Am J Respir Crit Care Med. 2018 02 01; 197(3):283-284. Maher TM. PMID: 28984465.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    102. Prevalence and Effects of Emphysema in Never-Smokers with Rheumatoid Arthritis Interstitial Lung Disease. EBioMedicine. 2018 Feb; 28:303-310. Jacob J, Song JW, Yoon HY, Cross G, Barnett J, Woo WL, Adams F, Kokosi M, Devaraj A, Renzoni E, Maher TM, Kim DS, Wells AU. PMID: 29422289.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    103. Diverse functions of clusterin promote and protect against the development of pulmonary fibrosis. Sci Rep. 2018 01 30; 8(1):1906. Peix L, Evans IC, Pearce DR, Simpson JK, Maher TM, McAnulty RJ. PMID: 29382921.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    104. Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF). Eur J Nucl Med Mol Imaging. 2018 05; 45(5):806-815. Win T, Screaton NJ, Porter JC, Ganeshan B, Maher TM, Fraioli F, Endozo R, Shortman RI, Hurrell L, Holman BF, Thielemans K, Rashidnasab A, Hutton BF, Lukey PT, Flynn A, Ell PJ, Groves AM. PMID: 29335764.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    105. Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterization. Respirology. 2018 07; 23(7):687-694. Keir GJ, Wort SJ, Kokosi M, George PM, Walsh SLF, Jacob J, Price L, Bax S, Renzoni EA, Maher TM, MacDonald P, Hansell DM, Wells AU. PMID: 29327393.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    106. Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema. Respirology. 2018 06; 23(6):593-599. Jacob J, Bartholmai BJ, Rajagopalan S, Karwoski R, Nair A, Walsh SLF, Barnett J, Cross G, Judge EP, Kokosi M, Renzoni E, Maher TM, Wells AU. PMID: 29237236.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    107. Pleuroparenchymal Fibroelastosis: A Review of Histopathologic Features and the Relationship Between Histologic Parameters and Survival. Am J Surg Pathol. 2017 Dec; 41(12):1683-1689. Khiroya R, Macaluso C, Montero MA, Wells AU, Chua F, Kokosi M, Maher TM, Devaraj A, Rice A, Renzoni EA, Nicholson AG. PMID: 28877057.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    108. Towards a global initiative for fibrosis treatment (GIFT). ERJ Open Res. 2017 Oct; 3(4). Molina-Molina M, Agusti A, Crestani B, Schwartz DA, Königshoff M, Chambers RC, Maher TM, Faner R, Mora AL, Rojas M, Antoniou KM, Sellares J. PMID: 29214157.
      View in: PubMed   Mentions:
    109. An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study. Lancet Respir Med. 2017 12; 5(12):946-955. Maher TM, Oballa E, Simpson JK, Porte J, Habgood A, Fahy WA, Flynn A, Molyneaux PL, Braybrooke R, Divyateja H, Parfrey H, Rassl D, Russell AM, Saini G, Renzoni EA, Duggan AM, Hubbard R, Wells AU, Lukey PT, Marshall RP, Jenkins RG. PMID: 29150411.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    110. Phenotypic characteristics associated with slow gait speed in idiopathic pulmonary fibrosis. Respirology. 2018 05; 23(5):498-506. Nolan CM, Maddocks M, Maher TM, Canavan JL, Jones SE, Barker RE, Patel S, Jacob J, Cullinan P, Man WD. PMID: 29139195.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    111. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study. Lancet Respir Med. 2017 11; 5(11):869-880. Allen RJ, Porte J, Braybrooke R, Flores C, Fingerlin TE, Oldham JM, Guillen-Guio B, Ma SF, Okamoto T, John AE, Obeidat M, Yang IV, Henry A, Hubbard RB, Navaratnam V, Saini G, Thompson N, Booth HL, Hart SP, Hill MR, Hirani N, Maher TM, McAnulty RJ, Millar AB, Molyneaux PL, Parfrey H, Rassl DM, Whyte MKB, Fahy WA, Marshall RP, Oballa E, Bossé Y, Nickle DC, Sin DD, Timens W, Shrine N, Sayers I, Hall IP, Noth I, Schwartz DA, Tobin MD, Wain LV, Jenkins RG. PMID: 29066090.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    112. Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study. Lancet Respir Med. 2017 11; 5(11):857-868. Herazo-Maya JD, Sun J, Molyneaux PL, Li Q, Villalba JA, Tzouvelekis A, Lynn H, Juan-Guardela BM, Risquez C, Osorio JC, Yan X, Michel G, Aurelien N, Lindell KO, Klesen MJ, Moffatt MF, Cookson WO, Zhang Y, Garcia JGN, Noth I, Prasse A, Bar-Joseph Z, Gibson KF, Zhao H, Herzog EL, Rosas IO, Maher TM, Kaminski N. PMID: 28942086.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    113. Time for an International Consensus on Hypersensitivity Pneumonitis. A Call to Arms. Am J Respir Crit Care Med. 2017 09 15; 196(6):665-666. Molyneaux PL, Maher TM. PMID: 28723313.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    114. Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries. BMC Pulm Med. 2017 Sep 15; 17(1):124. Maher TM, Molina-Molina M, Russell AM, Bonella F, Jouneau S, Ripamonti E, Axmann J, Vancheri C. PMID: 28915874.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    115. A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial. Lancet Respir Med. 2017 10; 5(10):806-815. Birring SS, Wijsenbeek MS, Agrawal S, van den Berg JWK, Stone H, Maher TM, Tutuncu A, Morice AH. PMID: 28923239.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    116. Validity, responsiveness and minimum clinically important difference of the incremental shuttle walk in idiopathic pulmonary fibrosis: a prospective study. Thorax. 2017 Sep 07. Nolan CM, Delogu V, Maddocks M, Patel S, Barker RE, Jones SE, Kon SSC, Maher TM, Cullinan P, Man WD. PMID: 28883090.
      View in: PubMed   Mentions: 4     Fields:    
    117. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study. Eur Respir J. 2017 08; 50(2). Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A. PMID: 28860269.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    118. Differential Expression of VEGF-Axxx Isoforms Is Critical for Development of Pulmonary Fibrosis. Am J Respir Crit Care Med. 2017 08 15; 196(4):479-493. Barratt SL, Blythe T, Jarrett C, Ourradi K, Shelley-Fraser G, Day MJ, Qiu Y, Harper S, Maher TM, Oltean S, Hames TJ, Scotton CJ, Welsh GI, Bates DO, Millar AB. PMID: 28661183.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    119. The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis. Oncotarget. 2017 Jul 25; 8(30):48737-48754. Conforti F, Davies ER, Calderwood CJ, Thatcher TH, Jones MG, Smart DE, Mahajan S, Alzetani A, Havelock T, Maher TM, Molyneaux PL, Thorley AJ, Tetley TD, Warner JA, Packham G, Ganesan A, Skipp PJ, Marshall BJ, Richeldi L, Sime PJ, O'Reilly KMA, Davies DE. PMID: 28467787.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    120. Home spirometry for idiopathic pulmonary fibrosis: ready for prime time? Eur Respir J. 2017 07; 50(1). Maher TM. PMID: 28729480.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    121. Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis. Arthritis Rheumatol. 2017 08; 69(8):1670-1678. Goh NS, Hoyles RK, Denton CP, Hansell DM, Renzoni EA, Maher TM, Nicholson AG, Wells AU. PMID: 28426895.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    122. Update in Interstitial Lung Disease 2016. Am J Respir Crit Care Med. 2017 07 15; 196(2):132-138. Wells AU, Maher TM. PMID: 28530124.
      View in: PubMed   Mentions: 2     Fields:    
    123. Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis. Eur Respir J. 2017 07; 50(1). Jacob J, Bartholmai BJ, Rajagopalan S, Kokosi M, Maher TM, Nair A, Karwoski R, Renzoni E, Walsh SLF, Hansell DM, Wells AU. PMID: 28679612.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    124. Cough in fibrotic lung disease: An unresolved challenge. Respirology. 2017 11; 22(8):1491-1492. Saunders P, Maher TM. PMID: 28677213.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    125. Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™). Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 106(4):75-81. Distler O, Brown KK, Distler JHW, Assassi S, Maher TM, Cottin V, Varga J, Coeck C, Gahlemann M, Sauter W, Schmidt H, Highland KB. PMID: 28664834.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    126. Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2017 06 15; 195(12):1640-1650. Molyneaux PL, Willis-Owen SAG, Cox MJ, James P, Cowman S, Loebinger M, Blanchard A, Edwards LM, Stock C, Daccord C, Renzoni EA, Wells AU, Moffatt MF, Cookson WOC, Maher TM. PMID: 28085486.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    127. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial. Trials. 2017 06 15; 18(1):275. Saunders P, Tsipouri V, Keir GJ, Ashby D, Flather MD, Parfrey H, Babalis D, Renzoni EA, Denton CP, Wells AU, Maher TM. PMID: 28619061.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    128. Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial. Trials. 2017 04 28; 18(1):201. Visca D, Tsipouri V, Mori L, Firouzi A, Fleming S, Farquhar M, Leung E, Maher TM, Cullinan P, Hopkinson N, Wells AU, Banya W, Whitty JA, Adamali H, Spencer LG, Sestini P, Renzoni EA. PMID: 28454553.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    129. Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone. Respiration. 2017; 93(6):415-423. Kreuter M, Spagnolo P, Wuyts W, Renzoni E, Koschel D, Bonella F, Maher TM, Kolb M, Weycker D, Kirchgässler KU, Costabel U. PMID: 28399537.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    130. Clinical trial research in focus: why do so many clinical trials fail in IPF? Lancet Respir Med. 2017 05; 5(5):372-374. Spagnolo P, Maher TM. PMID: 28412184.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    131. A lesson in plasticity: a 74-year-old man with plastic bronchitis. Thorax. 2017 11; 72(11):1055-1057. Shah A, Donovan J, Marino P, Shah PL, Devaraj A, Wechalekar K, Maher TM, Loebinger MR, Wilson R. PMID: 28373346.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    132. A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK. Pharmacoeconomics. 2017 04; 35(4):479-491. Rinciog C, Watkins M, Chang S, Maher TM, LeReun C, Esser D, Diamantopoulos A. PMID: 28039616.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    133. Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis. J Manag Care Spec Pharm. 2017 Mar; 23(3-b Suppl):S17-S24. Fisher M, Nathan SD, Hill C, Marshall J, Dejonckheere F, Thuresson PO, Maher TM. PMID: 28287347.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    134. Survival in Idiopathic Pulmonary Fibrosis: Perspectives from Pulmonary Arterial Hypertension. J Manag Care Spec Pharm. 2017 Mar; 23(3-b Suppl):S3-S4. Maher TM, Dejonckheere F, Nathan SD. PMID: 28287348.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    135. Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis. Respir Res. 2017 02 01; 18(1):29. Molyneaux PL, Cox MJ, Wells AU, Kim HC, Ji W, Cookson WO, Moffatt MF, Kim DS, Maher TM. PMID: 28143484.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    136. Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis. Thorax. 2017 02; 72(2):137-147. Alton EW, Beekman JM, Boyd AC, Brand J, Carlon MS, Connolly MM, Chan M, Conlon S, Davidson HE, Davies JC, Davies LA, Dekkers JF, Doherty A, Gea-Sorli S, Gill DR, Griesenbach U, Hasegawa M, Higgins TE, Hironaka T, Hyndman L, McLachlan G, Inoue M, Hyde SC, Innes JA, Maher TM, Moran C, Meng C, Paul-Smith MC, Pringle IA, Pytel KM, Rodriguez-Martinez A, Schmidt AC, Stevenson BJ, Sumner-Jones SG, Toshner R, Tsugumine S, Wasowicz MW, Zhu J. PMID: 27852956.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    137. Blood-based Diagnosis of Idiopathic Pulmonary Fibrosis. Fantasy or Reality? Am J Respir Crit Care Med. 2016 11 15; 194(10):1182-1184. Maher TM. PMID: 27845590.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    138. Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns. Eur Respir J. 2016 11; 48(5):1524-1526. Kreuter M, Wijsenbeek MS, Vasakova M, Spagnolo P, Kolb M, Costabel U, Weycker D, Kirchgaessler KU, Maher TM. PMID: 27799399.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    139. Reply: Daily Home Spirometry: A New Milestone in the Field of Pulmonary Fibrosis. Am J Respir Crit Care Med. 2016 10 15; 194(8):1034-1035. Russell AM, Maher TM. PMID: 27739889.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    140. Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2016 10 15; 194(8):989-997. Russell AM, Adamali H, Molyneaux PL, Lukey PT, Marshall RP, Renzoni EA, Wells AU, Maher TM. PMID: 27089018.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    141. Patient eligibility for anti-fibrotic therapy in idiopathic pulmonary fibrosis can be altered by use of different sets of reference values for calculation of FVC percent predicted. Respir Med. 2016 11; 120:131-133. Ward K, Spurr L, Goldman NR, Margaritopoulos GA, Kokosi M, Renzoni E, Chua F, Maher TM, Ward S, Wells AU. PMID: 27817810.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    142. Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis. Thorax. 2017 02; 72(2):148-153. Kreuter M, Bonella F, Maher TM, Costabel U, Spagnolo P, Weycker D, Kirchgaessler KU, Kolb M. PMID: 27708114.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    143. Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume. Thorax. 2017 Apr; 72(4):340-346. Kolb M, Richeldi L, Behr J, Maher TM, Tang W, Stowasser S, Hallmann C, du Bois RM. PMID: 27672117.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    144. Anti-acid treatment in patients with IPF: interpret results from post-hoc, subgroup, and exploratory analyses with great caution - Authors' reply. Lancet Respir Med. 2016 09; 4(9):e48. Kreuter M, Wuyts W, Renzoni E, Koschel D, Maher TM, Kolb M, Weycker D, Spagnolo P, Kirchgaessler KU, Herth FJF, Costabel U. PMID: 27599251.
      View in: PubMed   Mentions: 3     Fields:    
    145. Precision medicine in idiopathic pulmonary fibrosis. QJM. 2016 Sep; 109(9):585-587. Maher TM. PMID: 27512106.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    146. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. Am J Respir Crit Care Med. 2016 08 01; 194(3):265-75. Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, Lee JS, Maher TM, Wells AU, Antoniou KM, Behr J, Brown KK, Cottin V, Flaherty KR, Fukuoka J, Hansell DM, Johkoh T, Kaminski N, Kim DS, Kolb M, Lynch DA, Myers JL, Raghu G, Richeldi L, Taniguchi H, Martinez FJ. PMID: 27299520.
      View in: PubMed   Mentions: 144     Fields:    Translation:Humans
    147. Medicine and Me: a breath of fresh air for IPF. Lancet Respir Med. 2016 08; 4(8):615-616. Maher T. PMID: 27511633.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    148. Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia. BMC Genet. 2016 06 07; 17(1):74. Fingerlin TE, Zhang W, Yang IV, Ainsworth HC, Russell PH, Blumhagen RZ, Schwarz MI, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch DA, Groshong S, Collard HR, Wolters PJ, Bradford WZ, Kossen K, Seiwert SD, du Bois RM, Garcia CK, Devine MS, Gudmundsson G, Isaksson HJ, Kaminski N, Zhang Y, Gibson KF, Lancaster LH, Maher TM, Molyneaux PL, Wells AU, Moffatt MF, Selman M, Pardo A, Kim DS, Crapo JD, Make BJ, Regan EA, Walek DS, Daniel JJ, Kamatani Y, Zelenika D, Murphy E, Smith K, McKean D, Pedersen BS, Talbert J, Powers J, Markin CR, Beckman KB, Lathrop M, Freed B, Langefeld CD, Schwartz DA. PMID: 27266705.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    149. Recent advances in understanding idiopathic pulmonary fibrosis. F1000Res. 2016; 5. Daccord C, Maher TM. PMID: 27303645.
      View in: PubMed   Mentions: 20     Fields:    
    150. Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis. Eur Respir J. 2016 06; 47(6):1776-84. Kreuter M, Wijsenbeek MS, Vasakova M, Spagnolo P, Kolb M, Costabel U, Weycker D, Kirchgaessler KU, Maher TM. PMID: 27103382.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    151. Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF. Thorax. 2016 08; 71(8):701-11. Mercer PF, Woodcock HV, Eley JD, Platé M, Sulikowski MG, Durrenberger PF, Franklin L, Nanthakumar CB, Man Y, Genovese F, McAnulty RJ, Yang S, Maher TM, Nicholson AG, Blanchard AD, Marshall RP, Lukey PT, Chambers RC. PMID: 27103349.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    152. Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis. Lancet Respir Med. 2016 05; 4(5):381-9. Kreuter M, Wuyts W, Renzoni E, Koschel D, Maher TM, Kolb M, Weycker D, Spagnolo P, Kirchgaessler KU, Herth FJ, Costabel U. PMID: 27050871.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    153. Pulmonary Macrophages: A New Therapeutic Pathway in Fibrosing Lung Disease? Trends Mol Med. 2016 Apr; 22(4):303-316. Byrne AJ, Maher TM, Lloyd CM. PMID: 26979628.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimalsCells
    154. Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosis. Clin Sci (Lond). 2016 Apr; 130(8):575-86. Evans IC, Barnes JL, Garner IM, Pearce DR, Maher TM, Shiwen X, Renzoni EA, Wells AU, Denton CP, Laurent GJ, Abraham DJ, McAnulty RJ. PMID: 26744410.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    155. Aerobic Glycolysis and the Warburg Effect. An Unexplored Realm in the Search for Fibrosis Therapies? Am J Respir Crit Care Med. 2015 Dec 15; 192(12):1407-9. Maher TM. PMID: 26669469.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    156. Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives. Biomed Res Int. 2015; 2015:329481. Kreuter M, Bonella F, Wijsenbeek M, Maher TM, Spagnolo P. PMID: 26779535.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    157. Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi Technique. Adv Ther. 2015 Oct; 32(10):929-43. Maher TM, Whyte MK, Hoyles RK, Parfrey H, Ochiai Y, Mathieson N, Turnbull A, Williamson N, Bennett BM. PMID: 26498943.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    158. Improved correction for the tissue fraction effect in lung PET/CT imaging. Phys Med Biol. 2015 Sep 21; 60(18):7387-402. Holman BF, Cuplov V, Millner L, Hutton BF, Maher TM, Groves AM, Thielemans K. PMID: 26350580.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    159. Personalized medicine in idiopathic pulmonary fibrosis: facts and promises. Curr Opin Pulm Med. 2015 Sep; 21(5):470-8. Spagnolo P, Tzouvelekis A, Maher TM. PMID: 26132817.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    160. New guideline on treatment of idiopathic pulmonary fibrosis. Lancet Respir Med. 2015 Sep; 3(9):e31-e32. Spagnolo P, Bonella F, Maher TM. PMID: 26380887.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    161. Challenges in the classification of fibrotic ILD. Sarcoidosis Vasc Diffuse Lung Dis. 2015 Aug 03; 32 Suppl 1:4-9. Bendstrup E, Maher TM, Manali ED, Wijsenbeek M. PMID: 26237436.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    162. Nintedanib in idiopathic pulmonary fibrosis. Drugs Today (Barc). 2015 Jun; 51(6):345-56. Woodcock HV, Maher TM. PMID: 26261848.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    163. Transcriptional phenotyping of fibrotic lung disease: a new gold standard? Lancet Respir Med. 2015 Jun; 3(6):423-4. Maher TM. PMID: 26003388.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    164. Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy. Pharmacol Ther. 2015 Aug; 152:18-27. Spagnolo P, Maher TM, Richeldi L. PMID: 25946646.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    165. Rasch analysis and impact factor methods both yield valid and comparable measures of health status in interstitial lung disease. J Clin Epidemiol. 2015 Sep; 68(9):1019-27. Patel AS, Siegert RJ, Bajwah S, Brignall K, Gosker HR, Moxham J, Maher TM, Renzoni EA, Wells AU, Higginson IJ, Birring SS. PMID: 26004514.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    166. Year in review 2014: Interstitial lung disease, physiology, sleep and ventilation, acute respiratory distress syndrome, cystic fibrosis, bronchiectasis and rare lung disease. Respirology. 2015 Jul; 20(5):834-45. Maher TM, Piper A, Song Y, Restrepo MI, Eves ND. PMID: 25824415.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    167. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study. Lancet Respir Med. 2015 Jun; 3(6):462-72. Jenkins RG, Simpson JK, Saini G, Bentley JH, Russell AM, Braybrooke R, Molyneaux PL, McKeever TM, Wells AU, Flynn A, Hubbard RB, Leeming DJ, Marshall RP, Karsdal MA, Lukey PT, Maher TM. PMID: 25770676.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    168. Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis. Eur Respir Rev. 2015 Mar; 24(135):58-64. Cottin V, Maher T. PMID: 25726556.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    169. Combination therapy: the future of management for idiopathic pulmonary fibrosis? Lancet Respir Med. 2014 Nov; 2(11):933-942. PMID: 25439569.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    170. Detecting anxiety and depression in patients diagnosed with an interstitial lung disease. Can we do better? Respirology. 2014 Nov; 19(8):1095-6. Russell AM, Maher TM. PMID: 25302755.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    171. UK trainee experience in interstitial lung disease: results from a British Thoracic Society survey. Thorax. 2015 Feb; 70(2):183. PMID: 25352531.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    172. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2014 Oct 15; 190(8):906-13. Molyneaux PL, Cox MJ, Willis-Owen SA, Mallia P, Russell KE, Russell AM, Murphy E, Johnston SL, Schwartz DA, Wells AU, Cookson WO, Maher TM, Moffatt MF. PMID: 25184687.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCells
    173. Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2014 Jul 15; 190(2):208-17. Corte TJ, Keir GJ, Dimopoulos K, Howard L, Corris PA, Parfitt L, Foley C, Yanez-Lopez M, Babalis D, Marino P, Maher TM, Renzoni EA, Spencer L, Elliot CA, Birring SS, O'Reilly K, Gatzoulis MA, Wells AU, Wort SJ. PMID: 24937643.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    174. Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Jul 08; 31(2):82-90. Keir GJ, Walsh SL, Gatzoulis MA, Marino PS, Dimopoulos K, Alonso R, Raposeiras-Roubin S, Renzoni EA, Maher TM, Wells AU, Wort SJ. PMID: 25078636.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    175. Disease stratification in idiopathic pulmonary fibrosis: the dawn of a new era? Eur Respir J. 2014 May; 43(5):1233-6. Maher TM. PMID: 24789946.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    176. Respiratory microbiome in IPF: cause, effect, or biomarker? Lancet Respir Med. 2014 Jul; 2(7):511-3. PMID: 24767768.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    177. Immunosuppression for connective tissue disease-related pulmonary disease. Semin Respir Crit Care Med. 2014 Apr; 35(2):265-73. Maher TM. PMID: 24668541.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    178. Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events. Adv Ther. 2014 Apr; 31(4):375-91. Costabel U, Bendstrup E, Cottin V, Dewint P, Egan JJ, Ferguson J, Groves R, Hellström PM, Kreuter M, Maher TM, Molina-Molina M, Nordlind K, Sarafidis A, Vancheri C. PMID: 24639005.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    179. The treatment of idiopathic pulmonary fibrosis. F1000Prime Rep. 2014; 6:16. PMID: 24669297.
      View in: PubMed   Mentions:
    180. Case-based discussion from the Royal Devon and Exeter NHS Foundation Trust: a painful paradox. Thorax. 2014 Aug; 69(8):779-81. PMID: 24584169.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    181. Year in review 2013: Acute lung injury, interstitial lung diseases, sleep and physiology. Respirology. 2014 Apr; 19(3):428-37. PMID: 24708032.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    182. Pulmonary Langerhans cell histiocytosis (PLCH): a new UK register. Thorax. 2014 Aug; 69(8):766-7. PMID: 24482091.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    183. An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study. Lancet Respir Med. 2014 Feb; 2(2):123-30. PMID: 24503267.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    184. Rituximab in severe, treatment-refractory interstitial lung disease. Respirology. 2014 Apr; 19(3):353-9. PMID: 24286447.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    185. Evidence for a functional thymic stromal lymphopoietin signaling axis in fibrotic lung disease. J Immunol. 2013 Nov 01; 191(9):4867-79. Datta A, Alexander R, Sulikowski MG, Nicholson AG, Maher TM, Scotton CJ, Chambers RC. PMID: 24081992.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    186. Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis. Thorax. 2014 Mar; 69(3):287-8. PMID: 24029745.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    187. Beyond the diagnosis of idiopathic pulmonary fibrosis; the growing role of systems biology and stratified medicine. Curr Opin Pulm Med. 2013 Sep; 19(5):460-5. PMID: 23912190.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    188. The role of infection in the pathogenesis of idiopathic pulmonary fibrosis. Eur Respir Rev. 2013 Sep 01; 22(129):376-81. PMID: 23997064.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimals
    189. Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients. Eur J Nucl Med Mol Imaging. 2014 Feb; 41(2):337-42. PMID: 23942907.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    190. Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease. Respir Res. 2013 Aug 02; 14:80. PMID: 23915349.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    191. The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease. Respir Med. 2013 Sep; 107(9):1438-43. PMID: 23867809.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    192. Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib. Drug Des Devel Ther. 2013; 7:503-10. PMID: 23818761.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    193. PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery. Eur Respir Rev. 2013 Jun 01; 22(128):148-52. PMID: 23728868.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    194. Primary endpoints in phase 3 clinical trials in idiopathic pulmonary fibrosis: one step at a time. Am J Respir Crit Care Med. 2013 Jun 01; 187(11):1271-2. PMID: 23725621.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    195. Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis. Eur Respir J. 2013 Jul; 42(1):230-8. PMID: 23682111.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    196. Provision of home mechanical ventilation and sleep services for England survey. Thorax. 2013 Sep; 68(9):880-1. PMID: 23604459.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    197. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet. 2013 Jun; 45(6):613-20. PMID: 23583980.
      View in: PubMed   Mentions: 201     Fields:    Translation:HumansCells
    198. Year in review 2012: acute lung injury, interstitial lung diseases, sleep and physiology. Respirology. 2013 Apr; 18(3):555-64. PMID: 23336426.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    199. Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment. Thorax. 2013 Aug; 68(8):780-1. PMID: 23515438.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    200. Exercise-induced haemoptysis: a thoroughbred cause? Thorax. 2013 Jun; 68(6):599-600. PMID: 23404840.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    201. Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis. J Rheumatol. 2013 Apr; 40(4):435-46. PMID: 23378460.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    202. Obliterative bronchiolitis in fibreglass workers: a new occupational disease? Occup Environ Med. 2013 May; 70(5):357-9. PMID: 23322914.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    203. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis. Thorax. 2013 May; 68(5):436-41. PMID: 23321605.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    204. Successful treatment of progressive diffuse PEComatosis. Eur Respir J. 2012 Dec; 40(6):1578-80. PMID: 23204027.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    205. The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status. Thorax. 2013 Jan; 68(1):57-65. PMID: 23065052.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    206. Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts. Adv Biosci Biotechnol. 2012 Oct; 3(6A):657-664. Sisson TH, Maher TM, Ajayi IO, King JE, Higgins PD, Booth AJ, Sagana RL, Huang SK, White ES, Moore BB, Horowitz JC. PMID: 23355956.
      View in: PubMed   Mentions:
    207. Current and novel drug therapies for idiopathic pulmonary fibrosis. Drug Des Devel Ther. 2012; 6:261-72. PMID: 23055696.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimals
    208. Drug-/radiation-induced interstitial lung disease in the United Kingdom general population: incidence, all-cause mortality and characteristics at diagnosis. Respirology. 2012 Jul; 17(5):861-8. PMID: 22563933.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    209. Incidence of the pneumoconioses in the United Kingdom general population between 1997 and 2008. Respiration. 2012; 84(3):200-6. Amar RK, Jick SS, Rosenberg D, Maher TM, Meier CR. PMID: 22678015.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    210. The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax. 2012 Sep; 67(9):804-10. PMID: 22555278.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    211. Pulmonary function vascular index predicts prognosis in idiopathic interstitial pneumonia. Respirology. 2012 May; 17(4):674-80. PMID: 22212399.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    212. Year in review 2011: acute lung injury, interstitial lung diseases, physiology, sleep and lung cancer. Respirology. 2012 Apr; 17(3):554-62. PMID: 22248252.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    213. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J. 2012 Aug; 40(2):377-85. PMID: 22441748.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    214. Elevated nocturnal desaturation index predicts mortality in interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis. 2012 Mar; 29(1):41-50. PMID: 23311122.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    215. Diffuse cystic lung disease of unexplained cause with coexistent small airway disease: a possible causal relationship? Am J Surg Pathol. 2012 Feb; 36(2):228-34. PMID: 22082605.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    216. Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy. Eur Respir J. 2012 Sep; 40(3):641-8. PMID: 22282550.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    217. Idiopathic pulmonary fibrosis: pathobiology of novel approaches to treatment. Clin Chest Med. 2012 Mar; 33(1):69-83. PMID: 22365247.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    218. 18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials. Eur J Nucl Med Mol Imaging. 2012 Mar; 39(3):521-8. PMID: 22258710.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    219. Ambulatory oxygen in interstitial lung disease. Eur Respir J. 2011 Oct; 38(4):987-90. PMID: 21965506.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    220. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J. 2012 Mar; 39(3):661-8. PMID: 21920896.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    221. In search of the fibrotic epithelial cell: opportunities for a collaborative network. Thorax. 2012 Feb; 67(2):179-82. Jenkins G, Blanchard A, Borok Z, Bradding P, Ehrhardt C, Fisher A, Hirani N, Johnson S, Königshoff M, Maher TM, Millar A, Parfrey H, Scotton C, Tetley T, Thickett D, Wolters P. PMID: 21680569.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    222. Idiopathic pulmonary fibrosis-related pulmonary hypertension; an exercising diagnosis? Respirology. 2011 Apr; 16(3):381-3. Maher TM, Wells AU. PMID: 21299689.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    223. Year in review 2010: interstitial lung diseases, acute lung injury, sleep, physiology, imaging, bronchoscopic intervention and lung cancer. Respirology. 2011 Apr; 16(3):553-63. Eastwood PR, Takahashi K, Lee P, Maher TM. PMID: 21244574.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    224. If it was good enough for Aristotle...... Thorax. 2011 Mar; 66(3):183-84. Maher TM, Wells AU. PMID: 21233482.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    225. Sildenafil in idiopathic pulmonary fibrosis. N Engl J Med. 2010 11 25; 363(22):2169; author reply 2170-1. Maher TM. PMID: 21105804.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    226. Pirfenidone in idiopathic pulmonary fibrosis. Drugs Today (Barc). 2010 Jul; 46(7):473-82. Maher TM. PMID: 20683502.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    227. Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010 Jul 01; 182(1):73-82. Maher TM, Evans IC, Bottoms SE, Mercer PF, Thorley AJ, Nicholson AG, Laurent GJ, Tetley TD, Chambers RC, McAnulty RJ. PMID: 20203246.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    228. Year in review 2009: Interstitial lung diseases, acute injury, sleep, physiology, imaging and bronchoscopic intervention. Respirology. 2010 Jan; 15(1):172-81. Eastwood PR, Maher TM, Wells AU, Lam B. PMID: 20199638.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    229. Pulmonary fibrosis associated with psychotropic drug therapy: a case report. J Med Case Rep. 2009 Nov 16; 3:126. Thornton C, Maher TM, Hansell D, Nicholson AG, Wells AU. PMID: 20062766.
      View in: PubMed   Mentions: 3     Fields:    
    230. Lost in translation; from animal models of pulmonary fibrosis to human disease. Respirology. 2009 Sep; 14(7):915-6. Maher TM, Wells AU. PMID: 19740253.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    231. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J Clin Invest. 2009 Sep; 119(9):2550-63. Scotton CJ, Krupiczojc MA, Königshoff M, Mercer PF, Lee YC, Kaminski N, Morser J, Post JM, Maher TM, Nicholson AG, Moffatt JD, Laurent GJ, Derian CK, Eickelberg O, Chambers RC. PMID: 19652365.
      View in: PubMed   Mentions: 105     Fields:    Translation:HumansAnimalsCells
    232. Understanding nonspecific interstitial pneumonia: the need for a diagnostic gold standard. Am J Respir Crit Care Med. 2009 Feb 01; 179(3):255-6; author reply 256. Maher TM. PMID: 19158329.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    233. Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q). Am J Pathol. 2009 Apr; 174(4):1264-79. Xu MY, Porte J, Knox AJ, Weinreb PH, Maher TM, Violette SM, McAnulty RJ, Sheppard D, Jenkins G. PMID: 19147812.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansAnimalsCells
    234. Optimal treatment for idiopathic pulmonary fibrosis. Thorax. 2008 Dec; 63(12):1120-1; author reply 1121. Maher TM, Wells AU. PMID: 19020278.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    235. The diagnosis of idiopathic pulmonary fibrosis and its complications. Expert Opin Med Diagn. 2008 Dec; 2(12):1317-31. PMID: 23496780.
      View in: PubMed   Mentions: 2     Fields:    
    236. Vibration response imaging technology in healthy subjects. AJR Am J Roentgenol. 2008 Sep; 191(3):845-52. Yigla M, Gat M, Meyer JJ, Friedman PJ, Maher TM, Madison JM. PMID: 18716118.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    237. Native valve Aspergillus endocarditis complicating lung transplantation. J Heart Lung Transplant. 2008 Aug; 27(8):910-3. Maher TM, Carby MR, Hall AV, Banner NR, Burke MM, Dreyfus GD. PMID: 18656806.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    238. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med. 2008 Jun 01; 177(11):1248-54. Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, Corte TJ, Sander CR, Ratoff J, Devaraj A, Bozovic G, Denton CP, Black CM, du Bois RM, Wells AU. PMID: 18369202.
      View in: PubMed   Mentions: 178     Fields:    Translation:Humans
    239. Reproducibility of dynamically represented acoustic lung images from healthy individuals. Thorax. 2008 Jun; 63(6):542-8. Maher TM, Gat M, Allen D, Devaraj A, Wells AU, Geddes DM. PMID: 18024534.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    240. Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Eur Respir J. 2007 Nov; 30(5):835-9. Maher TM, Wells AU, Laurent GJ. PMID: 17978154.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansAnimals
    241. CT findings of varicella pneumonia after lung transplantation. AJR Am J Roentgenol. 2007 Jun; 188(6):W557-9. Maher TM, Gupta NK, Burke MM, Carby MR. PMID: 17515348.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    242. Acute breathlessness. Br J Hosp Med (Lond). 2007 Mar; 68(3):M40-3. Maher TM, Wells AU. PMID: 17419463.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    243. Highly polymorphic short tandem repeat analyses clarify complex molecular test results. Diagn Mol Pathol. 2001 Sep; 10(3):179-89. Lebo RV, Maher T, Farrer L, Fenerci EY, Milunsky JM. PMID: 11552721.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    244. Substituting lifestyle management for pharmacological control of blood pressure: a pilot study in Australian general practice. Blood Press. 2000; 9(5):267-74. Reid CM, Maher T, Jennings GL. PMID: 11193130.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    245. Vascular density does not predict future metastatic disease in clinical stage 1 non-seminomatous germ cell tumours of the testis. Histopathology. 1998 Mar; 32(3):217-24. Maher TM, Lee AH. PMID: 9568506.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    246. Afferent input from peripheral chemoreceptors in response to hypoxia and amino acid neurotransmitter generation in the medulla. Adv Exp Med Biol. 1996; 410:365-9. Kazemi H, Beagle J, Maher T, Hoop B. PMID: 9030326.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    247. Distressful events in the ICU as perceived by patients recovering from coronary artery bypass surgery. Heart Lung. 1994 Jul-Aug; 23(4):323-7. Pennock BE, Crawshaw L, Maher T, Price T, Kaplan PD. PMID: 7960858.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    248. Phase II study of merbarone (NSC 336628) in patients with advanced gastric carcinoma. Cancer Invest. 1994; 12(5):488-90. Ajani JA, Winn R, Baez L, Pollock T, Maher T, Hallinan-Fueger B, Newman J. PMID: 7922705.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    249. Interleukin-2 activity in patients with extensive small-cell lung cancer: a phase II trial of Cancer and Leukemia Group B. J Natl Cancer Inst. 1993 Feb 17; 85(4):316-20. Clamon G, Herndon J, Perry MC, Ozer H, Kreisman H, Maher T, Ellerton J, Green MR. PMID: 8381188.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    250. Surgical therapy for left ventricular aneurysms. A ten-year experience. Circulation. 1989 Jun; 79(6 Pt 2):I102-7. Magovern GJ, Sakert T, Simpson K, Laub GW, Park SB, Liebler G, Burkholder J, Maher T, Benckart D, Magovern GJ. PMID: 2720938.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Toby's Networks
    Concepts (662)
    Derived automatically from this person's publications.
    _
    Co-Authors (9)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _